These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25310139)

  • 1. HCV treatment uptake in people who have injected drugs - observations in a large cohort that received addiction treatment 1970-1984.
    Kielland KB; Amundsen EJ; Dalgard O
    Scand J Gastroenterol; 2014 Dec; 49(12):1465-72. PubMed ID: 25310139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS-FANTASIO study).
    Barré T; Marcellin F; Di Beo V; Delorme J; Rojas Rojas T; Mathurin P; Protopopescu C; Bailly F; Coste M; Authier N; Carrieri MP; Rolland B
    Addiction; 2020 Mar; 115(3):573-582. PubMed ID: 31595554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.
    Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S62-9. PubMed ID: 23884068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for hepatitis C virus infection increases survival of patients with pretreatment anemia.
    Mohanty A; Erqou S; McGinnis KA; Vanasse G; Freiberg MS; Sherman KE; Butt AA
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):741-7.e3. PubMed ID: 23376794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study.
    Hayashi K; Milloy MJ; Wood E; Dong H; Montaner JS; Kerr T
    J Int AIDS Soc; 2014; 17(1):19296. PubMed ID: 25391765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Berenguer J; Alvarez-Pellicer J; Martín PM; López-Aldeguer J; Von-Wichmann MA; Quereda C; Mallolas J; Sanz J; Tural C; Bellón JM; González-García J;
    Hepatology; 2009 Aug; 50(2):407-13. PubMed ID: 19575364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
    Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
    J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders.
    Fransen van de Putte DE; Makris M; Fischer K; Yee TT; Kirk L; van Erpecum KJ; Patch D; Posthouwer D; Mauser-Bunschoten EP
    J Hepatol; 2014 Jan; 60(1):39-45. PubMed ID: 23978717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study.
    Omland LH; Krarup H; Jepsen P; Georgsen J; Harritshøj LH; Riisom K; Jacobsen SE; Schouenborg P; Christensen PB; Sørensen HT; Obel N;
    J Hepatol; 2010 Jul; 53(1):36-42. PubMed ID: 20400197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study.
    Kielland KB; Skaug K; Amundsen EJ; Dalgard O
    J Hepatol; 2013 Jan; 58(1):31-7. PubMed ID: 22960427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care.
    Innes HA; Hutchinson SJ; Allen S; Bhattacharyya D; Bramley P; Delahooke TE; Dillon JF; Forrest E; Fraser A; Gillespie R; Goldberg DJ; Kennedy N; McDonald S; McLeod A; Mills PR; Morris J; Hayes P;
    Hepatology; 2011 Nov; 54(5):1547-58. PubMed ID: 22045672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.
    Grady BP; Vanhommerig JW; Schinkel J; Weegink CJ; Bruisten SM; Lindenburg CE; Prins M
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1302-7. PubMed ID: 22825643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can hepatitis C virus infection be eradicated in people who inject drugs?
    Grebely J; Dore GJ
    Antiviral Res; 2014 Apr; 104():62-72. PubMed ID: 24468275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of chronic hepatitis C virus (HCV) on survival of schizophrenic patients with co-occurring substance use disorders followed for ten years].
    Gimelfarb Y; Becalel E; Wolf A; Ben-Tzarfati M; Baruch Y
    Harefuah; 2014 Nov; 153(11):641-5, 688. PubMed ID: 25563021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus treatment and survival in patients with hepatitis C and human immunodeficiency virus co-infection and baseline anaemia.
    Erqou S; Mohanty A; McGinnis KA; Vanasse G; Freiberg MS; Sherman KE; Butt AA
    J Viral Hepat; 2013 Jul; 20(7):463-9. PubMed ID: 23730839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
    Schaefer M; Heinz A; Backmund M
    Addiction; 2004 Sep; 99(9):1167-75. PubMed ID: 15317637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort.
    Stenkvist J; Weiland O; Sönnerborg A; Blaxhult A; Falconer K
    Scand J Infect Dis; 2014 Sep; 46(9):624-32. PubMed ID: 24984040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
    Bini EJ; Bräu N; Currie S; Shen H; Anand BS; Hu KQ; Jeffers L; Ho SB; Johnson D; Schmidt WN; King P; Cheung R; Morgan TR; Awad J; Pedrosa M; Chang KM; Aytaman A; Simon F; Hagedorn C; Moseley R; Ahmad J; Mendenhall C; Waters B; Strader D; Sasaki AW; Rossi S; Wright TL
    Am J Gastroenterol; 2005 Aug; 100(8):1772-9. PubMed ID: 16086714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.